CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[Delayed Neurotoxicity Remains a Challenge in CAR T-Cell Therapy]]>

CAR T-cell therapyNegative
AI Analysis

Summary

Dr. Megan Melody discusses ongoing challenges with delayed neurotoxicity in CAR T-cell therapy, noting that while acute toxicities are well-managed, delayed neurotoxicity remains a clinical concern.

Importance:3/10
Sentiment:
-0.30
CAR T-cell therapyneurotoxicitysafetyadverse events

Read the original article

Published by Cancer Network on July 21, 2026 6:00 PM

Read Original